Alzheimer Disease and Dementia
Medicare Coverage of Aducanumab for Alzheimer Disease: The Impact of the Decision
- Propranolol Shows Potential as Pharmacokinetic Treatment for AD
- Medication Has Little Effect on Emotional Blunting in MDD
- Non-Alzheimer Dementia Risk Tied to Physical Activity During Leisure Time
- Naloxone Out-of-Pocket Expenses May Present Barrier for Uninsured
- Telehealth Services Usage for Opioid Use Disorder Increased During Pandemic
- Anxiety, Depression Scores Increased in Meniere Disease, Vertigo
- US Preventive Services Task Force Recommends Depression Screening for All Adults
- Acupuncture May Ease Anxiety in Patients With Parkinson Disease
- Toxoplasmosis Infection Has a Possible Causal Relationship With Bipolar Disorder
- Time and Perspective Affects Disease Trajectory in MDD, Anxiety
- Trial Evaluating Pfizer’s Quadrivalent mRNA Influenza Vaccine Begins
- Veterans’ Health: The Link Between Blast Exposure and Respiratory Symptoms
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
